25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EDTXF (Spectral Med Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Spectral Med Inc together

I guess you are interested in Spectral Med Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Spectral Med Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Spectral Med Inc’s Price Targets

I'm going to help you getting a better view of Spectral Med Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Spectral Med Inc

I send you an email if I find something interesting about Spectral Med Inc.

1. Quick Overview

1.1. Quick analysis of Spectral Med Inc (30 sec.)










1.2. What can you expect buying and holding a share of Spectral Med Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.10
Expected worth in 1 year
$-0.15
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.04
Return On Investment
-3.9%

For what price can you sell your share?

Current Price per Share
$1.14
Expected price per share
$0.615 - $1.311
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Spectral Med Inc (5 min.)




Live pricePrice per Share (EOD)
$1.14
Intrinsic Value Per Share
$-0.20 - $-0.13
Total Value Per Share
$-0.31 - $-0.24

2.2. Growth of Spectral Med Inc (5 min.)




Is Spectral Med Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$29.1m-$12.6m-$12.3m-49.4%

How much money is Spectral Med Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.8m-$3.3m-$521k-13.4%
Net Profit Margin-985.9%-1,051.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Spectral Med Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#122 / 128

Most Revenue
#116 / 128

Most Profit
#73 / 128

Most Efficient
#119 / 128
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Spectral Med Inc?

Welcome investor! Spectral Med Inc's management wants to use your money to grow the business. In return you get a share of Spectral Med Inc.

First you should know what it really means to hold a share of Spectral Med Inc. And how you can make/lose money.

Speculation

The Price per Share of Spectral Med Inc is $1.14. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Spectral Med Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Spectral Med Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.10. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Spectral Med Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%-0.01-1.2%-0.01-1.0%-0.01-1.0%-0.01-0.8%-0.01-0.5%
Usd Book Value Change Per Share0.00-0.3%-0.01-1.0%-0.01-0.9%-0.01-0.7%-0.01-0.5%0.00-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.3%-0.01-1.0%-0.01-0.9%-0.01-0.7%-0.01-0.5%0.00-0.3%
Usd Price Per Share0.60-0.48-0.32-0.35-0.34-0.38-
Price to Earnings Ratio-30.75--7.09--7.04--7.04--10.00--20.37-
Price-to-Total Gains Ratio-165.10--41.92--35.84--28.09--44.95--288.84-
Price to Book Ratio-5.92--5.44--7.55--13.36--72.31--8.13-
Price-to-Total Gains Ratio-165.10--41.92--35.84--28.09--44.95--288.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.14
Number of shares877
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (877 shares)-9.65-4.79
Gains per Year (877 shares)-38.61-19.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-39-490-19-29
20-77-880-38-48
30-116-1270-58-67
40-154-1660-77-86
50-193-2050-96-105
60-232-2440-115-124
70-270-2830-134-143
80-309-3220-153-162
90-348-3610-173-181
100-386-4000-192-200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%2.038.00.05.0%6.0126.01.04.5%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%27.0103.03.020.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0133.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%4.016.00.020.0%8.032.00.020.0%27.0103.03.020.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Spectral Med Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.011+201%-0.010+170%-0.008+128%-0.005+49%-0.003-12%
Book Value Per Share---0.102-0.087-14%-0.044-57%-0.048-53%-0.027-73%-0.007-93%
Current Ratio--0.1200.146-18%0.887-87%0.955-87%1.930-94%3.542-97%
Debt To Asset Ratio--8.3107.457+11%3.681+126%4.278+94%2.923+184%1.602+419%
Debt To Equity Ratio----0%-0%-0%0.643-100%1.477-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--141699426.000110183672.500+29%75977980.500+87%85019477.167+67%86092097.500+65%103703652.650+37%
Eps---0.005-0.014+177%-0.012+139%-0.012+136%-0.009+89%-0.006+27%
Ev To Ebitda Ratio---69.607-17.703-75%-9.044-87%-14.614-79%-15.424-78%-22.455-68%
Ev To Sales Ratio--60.01860.876-1%57.414+5%58.772+2%63.239-5%60.793-1%
Free Cash Flow Per Share---0.007-0.006-18%-0.006-24%-0.006-17%-0.006-18%-0.004-41%
Free Cash Flow To Equity Per Share--0.004-0.003+178%0.003+14%0.000+102%-0.001+125%0.000+101%
Gross Profit Margin--1.0001.0000%1.208-17%1.069-6%1.042-4%1.021-2%
Intrinsic Value_10Y_max---0.134----------
Intrinsic Value_10Y_min---0.205----------
Intrinsic Value_1Y_max---0.017----------
Intrinsic Value_1Y_min---0.024----------
Intrinsic Value_3Y_max---0.048----------
Intrinsic Value_3Y_min---0.069----------
Intrinsic Value_5Y_max---0.076----------
Intrinsic Value_5Y_min---0.111----------
Market Cap325834800.000+47%172606698.000136922071.000+26%90676395.000+90%100756313.667+71%95909759.200+80%107567642.450+60%
Net Profit Margin---2.378-9.859+315%-10.519+342%-9.237+288%-7.758+226%-5.057+113%
Operating Margin---0.932-8.150+774%-6.989+650%-7.006+651%-6.110+555%-4.179+348%
Operating Ratio--4.0695.991-32%7.971-49%6.515-38%6.448-37%4.825-16%
Pb Ratio-11.171-89%-5.918-5.444-8%-7.554+28%-13.363+126%-72.308+1122%-8.127+37%
Pe Ratio-58.046-89%-30.749-7.094-77%-7.039-77%-7.042-77%-10.004-67%-20.371-34%
Price Per Share1.140+47%0.6040.479+26%0.317+90%0.353+71%0.336+80%0.376+60%
Price To Free Cash Flow Ratio-38.892-89%-20.602-21.523+4%-16.625-19%-16.181-21%-15.130-27%-20.5710%
Price To Total Gains Ratio-311.672-89%-165.104-41.917-75%-35.838-78%-28.087-83%-44.951-73%-288.843+75%
Quick Ratio--0.0890.117-24%0.711-87%0.763-88%1.638-95%3.154-97%
Return On Assets---0.352-1.020+190%-0.733+109%-0.738+110%-0.548+56%-0.378+7%
Return On Equity----0%-0%-0%-0.1680%-0.5320%
Total Gains Per Share---0.004-0.011+201%-0.010+170%-0.008+128%-0.005+49%-0.003-12%
Usd Book Value---29167776.000-24999628.500-14%-12646920.000-57%-13621454.000-53%-7737054.600-73%-1983922.050-93%
Usd Book Value Change Per Share---0.004-0.011+201%-0.010+170%-0.008+128%-0.005+49%-0.003-12%
Usd Book Value Per Share---0.102-0.087-14%-0.044-57%-0.048-53%-0.027-73%-0.007-93%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--141699426.000110183672.500+29%75977980.500+87%85019477.167+67%86092097.500+65%103703652.650+37%
Usd Eps---0.005-0.014+177%-0.012+139%-0.012+136%-0.009+89%-0.006+27%
Usd Free Cash Flow---2094510.000-1727880.000-18%-1581409.500-24%-1729695.000-17%-1710383.400-18%-1241859.300-41%
Usd Free Cash Flow Per Share---0.007-0.006-18%-0.006-24%-0.006-17%-0.006-18%-0.004-41%
Usd Free Cash Flow To Equity Per Share--0.004-0.003+178%0.003+14%0.000+102%-0.001+125%0.000+101%
Usd Market Cap325834800.000+47%172606698.000136922071.000+26%90676395.000+90%100756313.667+71%95909759.200+80%107567642.450+60%
Usd Price Per Share1.140+47%0.6040.479+26%0.317+90%0.353+71%0.336+80%0.376+60%
Usd Profit---1403358.000-3880288.500+177%-3359202.000+139%-3098205.000+121%-2517840.600+79%-1834347.900+31%
Usd Revenue--590238.000459558.000+28%345031.500+71%373043.000+58%360858.300+64%481737.300+23%
Usd Total Gains Per Share---0.004-0.011+201%-0.010+170%-0.008+128%-0.005+49%-0.003-12%
 EOD+6 -2MRQTTM+21 -14YOY+22 -143Y+22 -145Y+22 -1510Y+19 -18

3.3 Fundamental Score

Let's check the fundamental score of Spectral Med Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-58.046
Price to Book Ratio (EOD)Between0-1-11.171
Net Profit Margin (MRQ)Greater than0-2.378
Operating Margin (MRQ)Greater than0-0.932
Quick Ratio (MRQ)Greater than10.089
Current Ratio (MRQ)Greater than10.120
Debt to Asset Ratio (MRQ)Less than18.310
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.352
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Spectral Med Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.196
Ma 20Greater thanMa 501.070
Ma 50Greater thanMa 1000.801
Ma 100Greater thanMa 2000.702
OpenGreater thanClose1.210
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Spectral Med Inc

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Fundamental data was last updated by Penke on 2025-09-13 18:30:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Spectral Med Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -237.8%Β means thatΒ $-2.38 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Spectral Med Inc:

  • The MRQ is -237.8%. The company is making a huge loss. -2
  • The TTM is -985.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-237.8%TTM-985.9%+748.1%
TTM-985.9%YOY-1,051.9%+66.0%
TTM-985.9%5Y-775.8%-210.1%
5Y-775.8%10Y-505.7%-270.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-237.8%-2.6%-235.2%
TTM-985.9%-6.5%-979.4%
YOY-1,051.9%-5.2%-1,046.7%
3Y-923.7%-9.2%-914.5%
5Y-775.8%-3.1%-772.7%
10Y-505.7%-1.6%-504.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Spectral Med Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • -35.2% Return on Assets means thatΒ Spectral Med Inc generatedΒ $-0.35 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Spectral Med Inc:

  • The MRQ is -35.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -102.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.2%TTM-102.0%+66.8%
TTM-102.0%YOY-73.3%-28.6%
TTM-102.0%5Y-54.8%-47.2%
5Y-54.8%10Y-37.8%-17.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.2%-0.6%-34.6%
TTM-102.0%-1.2%-100.8%
YOY-73.3%-1.1%-72.2%
3Y-73.8%-1.3%-72.5%
5Y-54.8%0.2%-55.0%
10Y-37.8%0.2%-38.0%
4.3.1.3. Return on Equity

Shows how efficient Spectral Med Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Spectral Med Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Spectral Med Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-16.8%+16.8%
5Y-16.8%10Y-53.2%+36.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.1%+0.1%
TTM--0.9%+0.9%
YOY--0.7%+0.7%
3Y--1.9%+1.9%
5Y-16.8%-1.2%-15.6%
10Y-53.2%-1.1%-52.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Spectral Med Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Spectral Med Inc is operatingΒ .

  • Measures how much profit Spectral Med Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of -93.2%Β means the company generated $-0.93 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Spectral Med Inc:

  • The MRQ is -93.2%. The company is operating very inefficient. -2
  • The TTM is -815.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-93.2%TTM-815.0%+721.8%
TTM-815.0%YOY-698.9%-116.1%
TTM-815.0%5Y-611.0%-204.1%
5Y-611.0%10Y-417.9%-193.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-93.2%-10.0%-83.2%
TTM-815.0%-12.4%-802.6%
YOY-698.9%-10.8%-688.1%
3Y-700.6%-0.3%-700.3%
5Y-611.0%3.0%-614.0%
10Y-417.9%2.9%-420.8%
4.3.2.2. Operating Ratio

Measures how efficient Spectral Med Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 4.07 means that the operating costs are $4.07 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Spectral Med Inc:

  • The MRQ is 4.069. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.991. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.069TTM5.991-1.922
TTM5.991YOY7.971-1.980
TTM5.9915Y6.448-0.457
5Y6.44810Y4.825+1.623
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0691.299+2.770
TTM5.9911.311+4.680
YOY7.9711.238+6.733
3Y6.5151.260+5.255
5Y6.4481.212+5.236
10Y4.8251.148+3.677
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Spectral Med Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Spectral Med Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 0.12Β means the company has $0.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Spectral Med Inc:

  • The MRQ is 0.120. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.146. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.120TTM0.146-0.026
TTM0.146YOY0.887-0.741
TTM0.1465Y1.930-1.784
5Y1.93010Y3.542-1.612
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1201.969-1.849
TTM0.1462.158-2.012
YOY0.8872.291-1.404
3Y0.9552.421-1.466
5Y1.9302.689-0.759
10Y3.5423.137+0.405
4.4.3.2. Quick Ratio

Measures if Spectral Med Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 0.09Β means the company can pay off $0.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Spectral Med Inc:

  • The MRQ is 0.089. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.117. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.117-0.028
TTM0.117YOY0.711-0.594
TTM0.1175Y1.638-1.521
5Y1.63810Y3.154-1.517
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0891.152-1.063
TTM0.1171.229-1.112
YOY0.7111.414-0.703
3Y0.7631.620-0.857
5Y1.6381.899-0.261
10Y3.1542.242+0.912
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Spectral Med Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Spectral Med IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Spectral Med Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 8.31Β means that Spectral Med Inc assets areΒ financed with 831.0% credit (debt) and the remaining percentage (100% - 831.0%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Spectral Med Inc:

  • The MRQ is 8.310. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 7.457. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ8.310TTM7.457+0.853
TTM7.457YOY3.681+3.777
TTM7.4575Y2.923+4.535
5Y2.92310Y1.602+1.320
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3100.401+7.909
TTM7.4570.426+7.031
YOY3.6810.397+3.284
3Y4.2780.389+3.889
5Y2.9230.413+2.510
10Y1.6020.444+1.158
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Spectral Med Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Spectral Med Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.643-0.643
5Y0.64310Y1.477-0.834
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.622-0.622
TTM-0.598-0.598
YOY-0.627-0.627
3Y-0.654-0.654
5Y0.6430.636+0.007
10Y1.4770.660+0.817
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Spectral Med Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Spectral Med Inc to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -30.75 means the investor is paying $-30.75Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Spectral Med Inc:

  • The EOD is -58.046. Based on the earnings, the company is expensive. -2
  • The MRQ is -30.749. Based on the earnings, the company is expensive. -2
  • The TTM is -7.094. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-58.046MRQ-30.749-27.297
MRQ-30.749TTM-7.094-23.655
TTM-7.094YOY-7.039-0.055
TTM-7.0945Y-10.004+2.910
5Y-10.00410Y-20.371+10.367
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-58.046-0.332-57.714
MRQ-30.749-0.483-30.266
TTM-7.094-0.417-6.677
YOY-7.039-0.253-6.786
3Y-7.0420.171-7.213
5Y-10.0048.472-18.476
10Y-20.3717.601-27.972
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Spectral Med Inc:

  • The EOD is -38.892. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.602. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -21.523. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.892MRQ-20.602-18.289
MRQ-20.602TTM-21.523+0.921
TTM-21.523YOY-16.625-4.899
TTM-21.5235Y-15.130-6.394
5Y-15.13010Y-20.571+5.442
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-38.8923.280-42.172
MRQ-20.6022.345-22.947
TTM-21.523-0.027-21.496
YOY-16.625-0.419-16.206
3Y-16.181-0.072-16.109
5Y-15.130-0.252-14.878
10Y-20.571-0.201-20.370
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Spectral Med Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -5.92 means the investor is paying $-5.92Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Spectral Med Inc:

  • The EOD is -11.171. Based on the equity, the company is expensive. -2
  • The MRQ is -5.918. Based on the equity, the company is expensive. -2
  • The TTM is -5.444. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.171MRQ-5.918-5.253
MRQ-5.918TTM-5.444-0.473
TTM-5.444YOY-7.554+2.109
TTM-5.4445Y-72.308+66.864
5Y-72.30810Y-8.127-64.181
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-11.1712.180-13.351
MRQ-5.9182.038-7.956
TTM-5.4442.113-7.557
YOY-7.5542.276-9.830
3Y-13.3632.478-15.841
5Y-72.3083.338-75.646
10Y-8.1274.369-12.496
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-06-302024-09-302024-12-312025-03-312025-06-30
Net Interest Income  -485-219-704-21-725-61-7862,2111,424



6.2. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets5,496
Total Liabilities45,672
Total Stockholder Equity-40,176
 As reported
Total Liabilities 45,672
Total Stockholder Equity+ -40,176
Total Assets = 5,496

Assets

Total Assets5,496
Total Current Assets4,584
Long-term Assets912
Total Current Assets
Cash And Cash Equivalents 3,100
Net Receivables 306
Inventory 244
Other Current Assets 934
Total Current Assets  (as reported)4,584
Total Current Assets  (calculated)4,584
+/-0
Long-term Assets
Property Plant Equipment 578
Intangible Assets 306
Long-term Assets  (as reported)912
Long-term Assets  (calculated)884
+/- 28

Liabilities & Shareholders' Equity

Total Current Liabilities38,302
Long-term Liabilities7,370
Total Stockholder Equity-40,176
Total Current Liabilities
Short-term Debt 15,033
Short Long Term Debt 14,901
Accounts payable 3,219
Other Current Liabilities 19,540
Total Current Liabilities  (as reported)38,302
Total Current Liabilities  (calculated)52,693
+/- 14,391
Long-term Liabilities
Long term Debt 2,259
Capital Lease Obligations 436
Long-term Liabilities  (as reported)7,370
Long-term Liabilities  (calculated)2,695
+/- 4,675
Total Stockholder Equity
Common Stock91,201
Retained Earnings -155,378
Other Stockholders Equity 24,001
Total Stockholder Equity (as reported)-40,176
Total Stockholder Equity (calculated)-40,176
+/-0
Other
Capital Stock91,201
Cash and Short Term Investments 3,100
Common Stock Shares Outstanding 284,906
Current Deferred Revenue510
Liabilities and Stockholders Equity 5,496
Net Debt 14,496
Net Invested Capital -23,016
Net Working Capital -33,718
Property Plant and Equipment Gross 578
Short Long Term Debt Total 17,596



6.3. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-30
> Total Assets 
1,077
6,613
4,981
4,500
0
0
0
16,800
45,600
44,400
42,800
40,900
38,600
36,400
33,100
30,600
38,100
35,300
31,800
42,500
39,100
35,900
33,300
30,300
28,000
27,900
24,400
22,300
20,200
17,300
16,100
16,200
16,200
14,992
14,026
13,448
19,960
22,035
20,944
18,071
15,864
17,532
16,995
14,042
12,275
14,414
20,685
19,706
18,267
16,300
17,367
15,580
13,935
12,646
11,367
11,558
10,250
9,682
8,007
9,095
8,709
8,674
7,980
7,565
7,418
6,930
7,085
6,856
5,882
5,342
5,032
21,282
19,837
18,671
17,295
15,498
14,169
22,091
20,651
18,486
16,399
14,146
12,586
10,320
12,993
11,252
9,438
5,909
3,646
13,789
11,862
9,144
13,281
10,568
8,459
15,461
12,557
9,375
7,100
6,059
5,336
4,284
3,473
3,341
7,229
6,423
6,977
6,975
6,172
5,174
4,006
10,726
12,824
10,001
8,163
8,389
7,053
14,007
11,555
9,635
6,256
3,809
11,996
8,958
6,331
8,716
5,211
4,894
10,075
8,219
5,320
4,062
5,496
5,4964,0625,3208,21910,0754,8945,2118,7166,3318,95811,9963,8096,2569,63511,55514,0077,0538,3898,16310,00112,82410,7264,0065,1746,1726,9756,9776,4237,2293,3413,4734,2845,3366,0597,1009,37512,55715,4618,45910,56813,2819,14411,86213,7893,6465,9099,43811,25212,99310,32012,58614,14616,39918,48620,65122,09114,16915,49817,29518,67119,83721,2825,0325,3425,8826,8567,0856,9307,4187,5657,9808,6748,7099,0958,0079,68210,25011,55811,36712,64613,93515,58017,36716,30018,26719,70620,68514,41412,27514,04216,99517,53215,86418,07120,94422,03519,96013,44814,02614,99216,20016,20016,10017,30020,20022,30024,40027,90028,00030,30033,30035,90039,10042,50031,80035,30038,10030,60033,10036,40038,60040,90042,80044,40045,60016,8000004,5004,9816,6131,077
   > Total Current Assets 
359
5,865
4,342
3,700
0
0
0
11,000
39,500
38,300
36,500
33,500
30,100
27,200
22,800
19,800
27,200
25,300
21,400
31,200
27,000
23,700
20,800
17,500
14,600
16,400
13,400
11,700
10,200
8,300
7,900
9,400
9,800
8,751
8,065
7,935
10,579
12,292
11,586
10,840
9,094
8,749
8,223
5,585
4,197
6,827
12,178
11,343
10,072
8,343
9,679
6,164
5,517
4,976
4,347
8,523
7,586
7,162
0
6,985
6,544
6,464
5,908
5,616
5,539
5,185
5,402
5,333
4,486
4,085
3,893
20,293
18,473
17,455
16,167
14,522
13,217
21,186
19,773
17,587
15,487
13,217
11,655
9,314
11,940
10,216
8,402
4,935
2,719
12,878
10,988
8,195
12,303
9,589
7,383
14,373
11,496
8,317
6,132
5,064
4,389
3,405
2,594
2,512
6,428
5,679
6,316
5,558
4,799
3,825
2,656
9,442
11,488
8,661
6,804
6,958
5,690
12,681
10,263
8,414
5,170
2,725
10,086
7,192
4,693
6,967
4,125
3,855
9,092
7,296
4,458
3,260
4,584
4,5843,2604,4587,2969,0923,8554,1256,9674,6937,19210,0862,7255,1708,41410,26312,6815,6906,9586,8048,66111,4889,4422,6563,8254,7995,5586,3165,6796,4282,5122,5943,4054,3895,0646,1328,31711,49614,3737,3839,58912,3038,19510,98812,8782,7194,9358,40210,21611,9409,31411,65513,21715,48717,58719,77321,18613,21714,52216,16717,45518,47320,2933,8934,0854,4865,3335,4025,1855,5395,6165,9086,4646,5446,98507,1627,5868,5234,3474,9765,5176,1649,6798,34310,07211,34312,1786,8274,1975,5858,2238,7499,09410,84011,58612,29210,5797,9358,0658,7519,8009,4007,9008,30010,20011,70013,40016,40014,60017,50020,80023,70027,00031,20021,40025,30027,20019,80022,80027,20030,10033,50036,50038,30039,50011,0000003,7004,3425,865359
       Cash And Cash Equivalents 
120
5,116
3,576
2,900
0
0
0
9,900
38,400
37,100
35,100
32,200
28,100
26,100
22,000
18,400
25,800
22,800
19,500
29,100
24,900
21,300
17,800
14,500
10,800
12,700
9,200
6,700
6,000
5,100
4,200
5,100
5,600
4,388
3,283
3,323
1,666
8,657
7,362
6,387
5,226
3,423
1,905
1,006
85
3,332
5,698
2,070
1,051
854
2,831
1,694
911
606
417
4,003
6,383
6,036
0
418
17
0
638
102
8
173
297
16
491
3,122
2,944
19,204
17,336
16,353
10,311
8,547
7,017
15,196
13,470
10,877
9,226
7,094
5,425
2,403
5,459
3,855
7,229
3,730
1,441
11,700
10,054
7,068
10,936
8,404
6,369
12,861
10,044
7,180
5,080
3,714
2,912
2,271
1,449
982
5,222
4,567
4,368
4,613
3,800
2,979
1,435
7,771
10,230
7,576
5,807
5,203
4,370
10,923
8,890
6,472
3,466
1,191
8,414
4,886
2,521
5,031
2,952
2,074
7,536
5,759
2,988
1,670
3,100
3,1001,6702,9885,7597,5362,0742,9525,0312,5214,8868,4141,1913,4666,4728,89010,9234,3705,2035,8077,57610,2307,7711,4352,9793,8004,6134,3684,5675,2229821,4492,2712,9123,7145,0807,18010,04412,8616,3698,40410,9367,06810,05411,7001,4413,7307,2293,8555,4592,4035,4257,0949,22610,87713,47015,1967,0178,54710,31116,35317,33619,2042,9443,12249116297173810263801741806,0366,3834,0034176069111,6942,8318541,0512,0705,6983,332851,0061,9053,4235,2266,3877,3628,6571,6663,3233,2834,3885,6005,1004,2005,1006,0006,7009,20012,70010,80014,50017,80021,30024,90029,10019,50022,80025,80018,40022,00026,10028,10032,20035,10037,10038,4009,9000002,9003,5765,116120
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,831
0
0
3,350
0
0
0
5,120
5,159
5,213
4,289
4,392
4,390
4,031
4,000
4,037
2,945
0
0
0
0
0
5,021
5,021
5,053
5,053
5,086
5,102
5,102
5,137
5,137
5,173
5,189
5,189
17
0
0
0
17
0
0
0
41
0
0
0
146
0
0
0
46
0
0
0
154
0
0
0
64
0
0
0
232
0
0
0
717
0
0
0
241
0
0
0
608
0
0
0
586
0
0
0058600060800024100071700023200064000154000460001460004100017000175,1895,1895,1735,1375,1375,1025,1025,0865,0535,0535,0215,021000002,9454,0374,0004,0314,3904,3924,2895,2135,1595,1200003,350002,83100000000000000000000003,20000000000000000000000000000000
       Net Receivables 
0
749
128
100
0
0
0
200
0
0
0
300
1,200
1,100
800
600
1,400
2,500
1,900
900
2,100
2,400
3,000
1,800
2,700
3,700
4,200
3,200
4,300
0
3,700
2,500
4,200
2,187
2,638
2,536
6,725
1,885
2,352
2,396
2,252
2,517
2,757
1,703
1,976
1,408
2,218
2,630
2,827
2,547
2,327
2,760
0
2,882
2,065
877
835
812
0
905
824
813
677
718
809
716
860
908
741
688
781
714
687
766
595
642
802
631
515
781
640
611
590
673
563
510
528
673
647
610
532
675
780
685
576
886
752
580
608
792
953
739
844
983
681
630
1,559
266
313
307
699
1,038
401
330
203
720
291
567
134
286
100
76
864
1,104
742
448
186
482
352
337
451
310
306
3063104513373524821864487421,104864761002861345672917202033304011,0386993073132661,55963068198384473995379260858075288657668578067553261064767352851056367359061164078151563180264259576668771478168874190886071680971867781382490508128358772,0652,88202,7602,3272,5472,8272,6302,2181,4081,9761,7032,7572,5172,2522,3962,3521,8856,7252,5362,6382,1874,2002,5003,70004,3003,2004,2003,7002,7001,8003,0002,4002,1009001,9002,5001,4006008001,1001,2003000002000001001287490
       Other Current Assets 
239
0
639
700
0
0
0
900
1,100
1,200
1,400
900
800
0
0
300
0
0
0
100
0
0
0
200
0
0
0
300
-100
0
0
500
2,811
491
436
382
657
389
599
521
361
941
1,229
1,019
775
683
2,734
5,416
4,671
3,457
3,111
359
364
33
281
250
263
188
112
197
191
85
55
160
118
72
42
168
122
68
45
133
110
85
31
136
109
66
407
568
274
162
226
647
311
305
330
343
449
389
236
234
320
463
195
301
264
173
200
299
248
173
110
249
293
193
192
486
391
275
182
371
509
412
446
668
733
792
975
1,137
1,141
798
468
853
1,142
1,184
13
980
932
882
790
1,079
934
9341,079790882932980131,1841,1428534687981,1411,137975792733668446412509371182275391486192193293249110173248299200173264301195463320234236389449343330305311647226162274568407661091363185110133456812216842721181605585191197112188263250281333643593,1113,4574,6715,4162,7346837751,0191,2299413615215993896573824364912,81150000-100300000200000100000300008009001,4001,2001,1009000007006390239
   > Long-term Assets 
718
749
639
800
0
0
0
5,800
6,100
6,100
6,300
7,400
8,500
9,200
10,300
10,800
10,900
10,000
10,400
11,300
12,100
12,200
12,500
12,800
13,400
11,500
11,000
10,600
10,000
9,000
8,200
6,800
6,400
6,241
5,961
5,513
9,381
9,743
9,358
7,231
6,770
8,783
8,772
8,457
8,078
7,587
8,507
8,363
8,195
7,957
7,688
9,416
8,418
7,670
7,020
3,035
2,664
2,520
0
2,110
2,165
2,210
2,072
1,949
1,879
1,745
1,683
1,523
1,396
1,257
1,139
989
1,364
1,216
1,128
976
952
905
878
899
912
929
931
1,006
1,053
1,036
1,036
974
927
911
874
949
978
979
1,076
1,088
1,061
1,058
968
995
947
879
879
829
801
744
661
1,417
1,373
1,349
1,350
1,284
1,336
1,340
1,359
1,431
1,363
1,326
1,292
1,221
1,086
1,084
1,910
1,766
1,638
1,749
1,086
1,039
983
923
862
802
912
9128028629239831,0391,0861,7491,6381,7661,9101,0841,0861,2211,2921,3261,3631,4311,3591,3401,3361,2841,3501,3491,3731,4176617448018298798799479959681,0581,0611,0881,0769799789498749119279741,0361,0361,0531,0069319299128998789059529761,1281,2161,3649891,1391,2571,3961,5231,6831,7451,8791,9492,0722,2102,1652,11002,5202,6643,0357,0207,6708,4189,4167,6887,9578,1958,3638,5077,5878,0788,4578,7728,7836,7707,2319,3589,7439,3815,5135,9616,2416,4006,8008,2009,00010,00010,60011,00011,50013,40012,80012,50012,20012,10011,30010,40010,00010,90010,80010,3009,2008,5007,4006,3006,1006,1005,800000800639749718
       Property Plant Equipment 
478
624
639
800
0
0
0
1,400
1,700
1,800
2,000
3,000
4,100
4,800
5,900
6,100
6,000
5,600
5,600
5,700
5,300
5,000
5,000
4,900
5,200
4,800
4,500
4,400
4,100
3,700
3,300
2,100
1,900
1,759
1,623
1,471
1,526
1,541
1,324
1,303
1,167
1,298
1,420
1,473
1,371
1,226
1,144
1,216
1,280
1,270
1,199
1,158
1,095
1,086
987
170
261
245
142
161
166
321
379
369
436
439
493
449
459
452
457
443
437
406
526
498
480
439
419
446
465
488
497
578
631
620
627
571
530
520
490
571
606
613
717
735
714
718
634
667
625
564
570
526
504
454
377
1,139
1,101
1,084
1,087
1,025
1,081
1,090
1,113
1,189
1,126
1,093
1,064
997
867
869
701
653
608
763
893
850
799
743
687
631
578
5786316877437998508937636086537018698679971,0641,0931,1261,1891,1131,0901,0811,0251,0871,0841,1011,1393774545045265705646256676347187147357176136065714905205305716276206315784974884654464194394804985264064374434574524594494934394363693793211661611422452611709871,0861,0951,1581,1991,2701,2801,2161,1441,2261,3711,4731,4201,2981,1671,3031,3241,5411,5261,4711,6231,7591,9002,1003,3003,7004,1004,4004,5004,8005,2004,9005,0005,0005,3005,7005,6005,6006,0006,1005,9004,8004,1003,0002,0001,8001,7001,400000800639624478
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,332
1,344
1,440
1,570
1,563
1,630
1,614
1,586
1,675
1,757
1,748
1,725
144
2,114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000000002,1141441,7251,7481,7571,6751,5861,6141,6301,5631,5701,4401,3441,33200000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
998
913
834
794
0
0
0
0
0
0
0
000000079483491399800000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
4,400
4,300
4,200
4,100
4,000
3,800
3,700
3,600
3,500
3,400
3,300
3,200
3,100
4,000
4,000
3,800
3,800
3,600
2,400
2,300
2,100
2,000
1,900
1,800
1,700
1,600
1,455
1,341
1,227
0
5,586
5,354
5,123
4,891
6,773
6,542
2,114
2,114
2,114
2,114
2,114
2,114
2,114
2,114
5,441
5,288
5,135
2,887
2,353
2,235
2,117
1,734
1,949
1,831
1,713
1,529
1,412
1,294
1,176
1,058
941
823
706
588
470
854
736
602
478
802
631
459
453
640
611
434
428
422
416
409
403
397
391
384
378
372
366
359
353
347
340
334
328
322
315
309
235
225
290
284
278
272
265
263
259
255
250
246
242
237
233
228
224
219
215
211
200
196
192
193
189
184
180
175
171
306
3061711751801841891931921962002112152192242282332372422462502552592632652722782842902252353093153223283343403473533593663723783843913974034094164224284346116404534596318024786027368544705887068239411,0581,1761,2941,4121,5291,7131,8311,9491,7342,1172,2352,3532,8875,1355,2885,4412,1142,1142,1142,1142,1142,1142,1142,1146,5426,7734,8915,1235,3545,58601,2271,3411,4551,6001,7001,8001,9002,0002,1002,3002,4003,6003,8003,8004,0004,0003,1003,2003,3003,4003,5003,6003,7003,8004,0004,1004,2004,3004,4000000000
       Long-term Assets Other 
239
125
0
0
0
0
0
0
100
100
200
400
600
700
800
1,200
1,500
1,100
1,600
2,500
2,800
3,200
3,700
4,100
4,600
4,300
4,200
4,100
3,900
3,400
3,100
3,000
2,900
3,027
2,997
2,815
7,855
2,616
2,680
805
712
712
810
4,870
4,593
4,247
5,249
5,033
4,801
4,573
4,375
2,817
2,035
1,305
1,032
512
168
158
0
0
168
176
164
168
149
130
0
133
114
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
790
1,373
1,349
1,350
1,284
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,2841,3501,3491,373790000000000000000000000000000000000000001141330130149168164176168001581685121,0321,3052,0352,8174,3754,5734,8015,0335,2494,2474,5934,8708107127128052,6802,6167,8552,8152,9973,0272,9003,0003,1003,4003,9004,1004,2004,3004,6004,1003,7003,2002,8002,5001,6001,1001,5001,200800700600400200100100000000125239
> Total Liabilities 
598
624
511
700
0
0
0
900
1,200
800
1,100
1,600
2,400
1,600
1,800
2,200
2,200
2,200
1,800
3,400
3,100
3,200
3,700
4,000
4,400
7,500
6,800
6,300
6,500
6,000
6,300
6,900
6,800
7,407
7,128
7,641
8,824
8,786
9,521
9,886
9,044
11,520
11,461
10,200
9,168
3,544
10,315
10,677
10,504
10,258
10,100
10,253
10,268
10,485
10,979
10,820
2,667
2,516
2,013
2,281
2,272
2,619
2,537
2,549
2,799
2,621
3,034
3,209
2,936
2,793
3,667
2,337
2,153
2,260
1,548
958
1,315
1,231
1,712
1,703
1,736
1,533
2,012
1,746
1,975
2,552
3,742
3,183
3,319
2,559
3,042
2,496
2,857
2,884
3,026
2,995
3,492
2,581
1,278
889
1,139
845
638
517
614
470
607
1,574
1,398
1,589
1,746
10,447
9,955
8,649
8,832
8,617
7,525
7,514
7,472
7,484
6,960
7,411
14,519
13,284
13,609
18,867
21,760
25,031
32,918
39,501
32,865
42,798
45,672
45,67242,79832,86539,50132,91825,03121,76018,86713,60913,28414,5197,4116,9607,4847,4727,5147,5258,6178,8328,6499,95510,4471,7461,5891,3981,5746074706145176388451,1398891,2782,5813,4922,9953,0262,8842,8572,4963,0422,5593,3193,1833,7422,5521,9751,7462,0121,5331,7361,7031,7121,2311,3159581,5482,2602,1532,3373,6672,7932,9363,2093,0342,6212,7992,5492,5372,6192,2722,2812,0132,5162,66710,82010,97910,48510,26810,25310,10010,25810,50410,67710,3153,5449,16810,20011,46111,5209,0449,8869,5218,7868,8247,6417,1287,4076,8006,9006,3006,0006,5006,3006,8007,5004,4004,0003,7003,2003,1003,4001,8002,2002,2002,2001,8001,6002,4001,6001,1008001,200900000700511624598
   > Total Current Liabilities 
598
499
383
700
0
0
0
800
1,000
800
1,100
1,600
2,200
1,500
1,400
1,700
1,600
1,800
1,400
3,000
2,800
3,000
3,600
3,900
4,300
5,700
5,100
5,100
4,300
3,400
3,300
3,300
3,100
3,723
3,487
3,860
3,441
3,207
3,900
4,526
3,887
4,729
4,769
4,235
3,661
3,177
3,943
3,976
3,489
3,356
2,898
2,511
1,986
1,663
1,617
1,224
827
639
432
396
346
653
379
353
567
351
540
3,209
2,936
2,793
3,413
2,116
1,964
2,103
1,322
958
1,315
1,231
1,712
1,703
1,736
1,533
2,012
1,746
1,975
2,552
3,742
3,183
3,319
2,559
3,042
2,496
2,857
2,884
3,026
2,995
3,492
2,581
1,278
889
1,139
845
638
517
614
470
607
849
691
902
1,079
3,952
3,647
2,529
2,902
2,877
1,975
2,155
2,303
2,505
2,172
2,815
3,959
2,901
3,520
3,192
10,242
10,758
15,034
33,927
27,445
37,532
38,302
38,30237,53227,44533,92715,03410,75810,2423,1923,5202,9013,9592,8152,1722,5052,3032,1551,9752,8772,9022,5293,6473,9521,0799026918496074706145176388451,1398891,2782,5813,4922,9953,0262,8842,8572,4963,0422,5593,3193,1833,7422,5521,9751,7462,0121,5331,7361,7031,7121,2311,3159581,3222,1031,9642,1163,4132,7932,9363,2095403515673533796533463964326398271,2241,6171,6631,9862,5112,8983,3563,4893,9763,9433,1773,6614,2354,7694,7293,8874,5263,9003,2073,4413,8603,4873,7233,1003,3003,3003,4004,3005,1005,1005,7004,3003,9003,6003,0002,8003,0001,4001,8001,6001,7001,4001,5002,2001,6001,1008001,000800000700383499598
       Short-term Debt 
120
0
0
100
0
0
0
100
100
100
100
100
100
100
300
300
400
300
400
400
400
400
400
300
200
300
1,100
1,000
900
900
1,000
1,000
1,100
1,019
1,038
1,084
622
470
484
454
401
2,438
651
1,792
1,280
1,024
1,471
1,130
1,374
1,518
970
929
895
675
859
0
0
0
0
0
35
349
0
0
195
0
0
2,598
2,254
0
2,336
1,271
1,295
1,319
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
0
0
71
73
75
77
79
81
83
85
87
89
91
92
93
94
95
175
97
98
121
385
401
459
13,016
14,554
14,945
15,033
15,03314,94514,55413,01645940138512198971759594939291898785838179777573710033000000000000000000000000000001,3191,2951,2712,33602,2542,598001950034935000008596758959299701,5181,3741,1301,4711,0241,2801,7926512,4384014544844706221,0841,0381,0191,1001,0001,0009009001,0001,10030020030040040040040040030040030030010010010010010010010000010000120
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79
0
0
0
264
278
334
12,890
14,425
14,815
14,901
14,90114,81514,42512,8903342782640007900000000000000400000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
359
499
383
600
0
0
0
600
900
600
900
1,400
2,100
1,400
1,100
1,400
1,300
1,400
1,000
2,600
2,400
2,600
3,200
3,600
4,100
5,500
4,000
3,900
3,400
2,500
2,300
2,100
2,000
2,494
2,239
2,566
2,609
2,527
3,047
3,201
2,761
2,082
2,337
2,223
2,245
2,085
2,472
2,256
2,090
1,817
1,566
1,582
1,091
988
758
1,224
827
639
432
396
311
304
379
353
372
351
444
263
384
2,295
1,024
832
628
762
1,322
882
1,264
1,206
1,351
1,627
1,645
1,507
861
1,672
1,925
2,527
1,539
3,103
3,236
2,532
992
2,411
2,783
2,815
874
2,828
3,387
2,511
399
758
1,043
784
359
514
611
441
199
524
472
688
298
3,184
783
788
1,161
2,119
1,193
1,335
444
1,670
1,410
2,015
1,650
2,135
2,724
2,314
1,596
2,611
2,784
3,004
990
4,321
3,219
3,2194,3219903,0042,7842,6111,5962,3142,7242,1351,6502,0151,4101,6704441,3351,1932,1191,1617887833,1842986884725241994416115143597841,0437583992,5113,3872,8288742,8152,7832,4119922,5323,2363,1031,5392,5271,9251,6728611,5071,6451,6271,3511,2061,2648821,3227626288321,0242,2953842634443513723533793043113964326398271,2247589881,0911,5821,5661,8172,0902,2562,4722,0852,2452,2232,3372,0822,7613,2013,0472,5272,6092,5662,2392,4942,0002,1002,3002,5003,4003,9004,0005,5004,1003,6003,2002,6002,4002,6001,0001,4001,3001,4001,1001,4002,1001,400900600900600000600383499359
       Other Current Liabilities 
120
0
0
0
0
0
0
100
0
100
100
100
0
0
0
0
-100
100
0
0
0
0
0
0
0
-100
0
200
0
0
0
200
0
210
210
210
210
134
232
545
1
132
1,465
150
101
50
0
562
19
17
345
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
540
332
446
305
1,077
845
669
784
0
78
51
25
259
77
89
26
1,052
73
48
25
2,097
72
78
24
1,901
85
59
69
1,976
128
81
70
873
98
0
61
276
6
6
29
301
71
10
8
704
689
2,111
990
980
671
693
729
1,767
742
668
705
2,134
0
698
0
7,534
7,746
11,266
17,405
11,521
17,546
19,540
19,54017,54611,52117,40511,2667,7467,534069802,1347056687421,7677296936719809902,1116897048107130129662766109887370811281,9766959851,9012478722,0972548731,05226897725925517807846698451,07730544633254000000000000000034517195620501011501,465132154523213421021021021002000002000-1000000000100-10000001001001000100000000120
   > Long-term Liabilities 
120
125
128
100
0
0
0
100
200
100
0
100
200
100
400
500
600
400
400
400
300
200
100
100
100
1,800
1,700
1,200
2,200
2,600
3,000
3,600
3,700
3,684
3,641
3,781
5,383
5,579
5,621
5,360
5,157
6,791
6,692
5,965
5,507
367
6,372
6,701
7,015
6,902
7,202
7,742
8,282
8,822
9,362
9,596
1,840
1,877
0
1,885
1,926
1,966
2,158
2,196
2,232
2,270
2,494
0
0
0
254
221
189
157
226
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
725
707
687
667
6,495
6,308
6,120
5,930
5,740
5,550
5,359
5,169
4,979
4,788
4,596
10,560
10,383
10,089
15,675
11,518
14,273
17,884
5,574
5,420
5,266
7,370
7,3705,2665,4205,57417,88414,27311,51815,67510,08910,38310,5604,5964,7884,9795,1695,3595,5505,7405,9306,1206,3086,495667687707725000000000000000000000000000000002261571892212540002,4942,2702,2322,1962,1581,9661,9261,88501,8771,8409,5969,3628,8228,2827,7427,2026,9027,0156,7016,3723675,5075,9656,6926,7915,1575,3605,6215,5795,3833,7813,6413,6843,7003,6003,0002,6002,2001,2001,7001,8001001001002003004004004006005004001002001000100200100000100128125120
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
471
426
383
352
299
277
234
198
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
143
139
131
265
221
203
181
241
218
178
153
227
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,849
5,682
5,515
5,348
5,181
5,014
4,846
4,679
4,512
4,345
4,178
4,011
0
3,676
0
0
0
0
0
0
0
0
000000003,67604,0114,1784,3454,5124,6794,8465,0145,1815,3485,5155,6825,849000000000000000000000000000000000000227153178218241181203221265131139143150000000000000000000000061982342772993523834264710000000000000000000000000000000
> Total Stockholder Equity
478
5,990
4,470
3,800
0
0
0
15,900
44,400
43,600
41,700
39,300
36,200
34,800
31,300
28,400
35,900
33,100
30,000
39,100
36,000
32,700
29,600
26,300
23,600
20,400
17,600
16,000
13,700
11,300
9,800
9,300
9,400
7,585
6,898
5,807
11,136
13,249
11,423
8,185
6,820
6,012
5,534
3,842
3,107
10,870
10,370
9,029
7,763
6,042
7,267
5,327
3,667
2,161
388
738
7,583
7,166
5,994
6,814
6,437
6,055
5,443
5,016
4,619
4,309
4,051
3,647
2,946
2,549
1,365
18,945
17,684
16,411
15,747
14,540
12,854
20,860
18,939
16,783
14,663
12,613
10,574
8,574
11,018
8,700
5,696
2,726
327
11,230
8,820
6,648
10,424
7,684
5,433
12,466
9,065
6,794
5,822
5,170
4,197
3,439
2,835
2,824
6,615
5,953
6,370
5,401
4,774
3,585
2,260
279
2,869
1,352
-669
-228
-472
6,493
4,083
2,151
-704
-3,602
-2,523
-4,326
-7,278
-10,151
-16,549
-20,137
-22,843
-31,282
-27,545
-38,736
-40,176
-40,176-38,736-27,545-31,282-22,843-20,137-16,549-10,151-7,278-4,326-2,523-3,602-7042,1514,0836,493-472-228-6691,3522,8692792,2603,5854,7745,4016,3705,9536,6152,8242,8353,4394,1975,1705,8226,7949,06512,4665,4337,68410,4246,6488,82011,2303272,7265,6968,70011,0188,57410,57412,61314,66316,78318,93920,86012,85414,54015,74716,41117,68418,9451,3652,5492,9463,6474,0514,3094,6195,0165,4436,0556,4376,8145,9947,1667,5837383882,1613,6675,3277,2676,0427,7639,02910,37010,8703,1073,8425,5346,0126,8208,18511,42313,24911,1365,8076,8987,5859,4009,3009,80011,30013,70016,00017,60020,40023,60026,30029,60032,70036,00039,10030,00033,10035,90028,40031,30034,80036,20039,30041,70043,60044,40015,9000003,8004,4705,990478
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,714
57,711
56,596
57,271
54,074
59,054
59,270
58,534
58,353
61,538
58,804
59,337
63,565
69,409
71,873
75,012
73,959
72,716
76,817
82,435
82,234
81,147
85,486
85,288
85,120
101,529
2,338
2,161
2,182
2,389
2,546
2,532
2,460
2,472
2,371
2,074
2,524
2,524
2,361
2,399
20,933
19,974
20,679
17,591
18,077
18,204
25,850
26,577
27,101
27,101
27,101
27,101
27,101
32,556
32,692
33,957
33,957
33,957
46,879
46,879
46,931
53,099
53,011
53,058
62,918
62,915
63,216
63,084
63,084
63,214
63,221
63,225
63,345
66,646
66,646
66,646
66,646
66,796
66,796
66,837
68,249
71,858
71,777
71,870
74,005
76,853
84,357
84,357
84,502
84,509
84,688
87,050
87,050
87,061
87,061
87,061
87,561
88,501
89,871
90,566
90,897
91,201
91,20190,89790,56689,87188,50187,56187,06187,06187,06187,05087,05084,68884,50984,50284,35784,35776,85374,00571,87071,77771,85868,24966,83766,79666,79666,64666,64666,64666,64663,34563,22563,22163,21463,08463,08463,21662,91562,91853,05853,01153,09946,93146,87946,87933,95733,95733,95732,69232,55627,10127,10127,10127,10127,10126,57725,85018,20418,07717,59120,67919,97420,9332,3992,3612,5242,5242,0742,3712,4722,4602,5322,5462,3892,1822,1612,338101,52985,12085,28885,48681,14782,23482,43576,81772,71673,95975,01271,87369,40963,56559,33758,80461,53858,35358,53459,27059,05454,07457,27156,59657,71157,7140000000000000000000000000000000
   Retained Earnings 
-837
-3,244
3,065
-3,600
0
0
0
-7,000
-8,600
-11,100
-13,000
-16,000
-19,300
-23,400
-27,000
-30,000
-32,800
-35,600
-38,600
-43,500
-46,700
-49,900
-53,100
-56,400
-59,100
-62,300
-65,100
-66,700
-69,100
-71,700
-73,200
-74,300
-76,000
-77,853
-78,544
-79,700
-78,271
-79,941
-81,763
-85,069
-86,485
-87,328
-87,810
-89,502
-90,404
-88,250
-90,055
-91,658
-93,056
-94,942
-97,054
-99,016
-100,710
-102,251
-104,058
-103,671
-98,920
-431
0
-1,228
-1,607
-1,989
-2,687
-3,135
-3,554
-3,886
-4,189
-4,593
-5,294
-5,723
-6,953
-8,896
-10,166
-11,456
-13,520
-14,853
-16,553
-18,168
-20,108
-22,356
-24,507
-26,584
-28,651
-30,728
-33,768
-36,285
-39,958
-43,133
-45,584
-47,596
-49,450
-51,715
-54,081
-56,797
-59,197
-62,191
-65,689
-68,322
-69,346
-70,308
-71,423
-72,243
-73,285
-73,976
-75,486
-76,195
-75,751
-76,744
-77,796
-79,197
-80,611
-84,036
-85,985
-87,562
-89,709
-91,354
-93,875
-95,942
-98,494
-101,182
-104,137
-107,272
-109,744
-111,521
-115,460
-118,851
-125,437
-129,597
-133,999
-143,993
-140,839
-153,444
-155,378
-155,378-153,444-140,839-143,993-133,999-129,597-125,437-118,851-115,460-111,521-109,744-107,272-104,137-101,182-98,494-95,942-93,875-91,354-89,709-87,562-85,985-84,036-80,611-79,197-77,796-76,744-75,751-76,195-75,486-73,976-73,285-72,243-71,423-70,308-69,346-68,322-65,689-62,191-59,197-56,797-54,081-51,715-49,450-47,596-45,584-43,133-39,958-36,285-33,768-30,728-28,651-26,584-24,507-22,356-20,108-18,168-16,553-14,853-13,520-11,456-10,166-8,896-6,953-5,723-5,294-4,593-4,189-3,886-3,554-3,135-2,687-1,989-1,607-1,2280-431-98,920-103,671-104,058-102,251-100,710-99,016-97,054-94,942-93,056-91,658-90,055-88,250-90,404-89,502-87,810-87,328-86,485-85,069-81,763-79,941-78,271-79,700-78,544-77,853-76,000-74,300-73,200-71,700-69,100-66,700-65,100-62,300-59,100-56,400-53,100-49,900-46,700-43,500-38,600-35,600-32,800-30,000-27,000-23,400-19,300-16,000-13,000-11,100-8,600-7,000000-3,6003,065-3,244-837
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
1,316
9,234
1,405
7,400
0
0
0
22,900
53,000
54,700
54,700
55,300
55,500
58,200
58,300
58,400
68,700
68,700
68,600
69,100
82,700
82,600
82,700
82,700
82,700
82,700
82,700
82,700
82,800
83,000
83,000
83,600
85,400
85,438
85,442
85,507
89,407
93,190
93,186
93,254
93,304
93,316
93,320
93,320
93,487
97,230
97,290
96,864
96,931
96,951
99,169
99,446
99,446
99,446
99,446
99,446
101,529
2,609
0
2,524
2,524
2,524
2,524
2,524
2,524
2,524
8,240
5,716
5,716
8,272
8,318
27,841
27,850
27,867
29,267
29,393
21,234
30,841
39,047
3,864
3,864
3,864
3,864
3,864
3,864
3,864
3,864
3,864
3,864
8,413
7,849
7,826
7,826
7,849
7,849
7,849
7,849
7,849
7,689
7,849
7,849
7,849
7,849
7,981
9,911
7,981
7,981
7,981
7,981
7,981
7,981
7,981
7,981
7,981
17,170
17,121
16,550
7,985
7,985
7,985
18,924
18,982
20,171
20,145
21,121
21,639
21,827
21,899
22,655
22,840
22,728
10,149
24,001
24,00110,14922,72822,84022,65521,89921,82721,63921,12120,14520,17118,98218,9247,9857,9857,98516,55017,12117,1707,9817,9817,9817,9817,9817,9817,9817,9817,9819,9117,9817,8497,8497,8497,8497,6897,8497,8497,8497,8497,8497,8267,8267,8498,4133,8643,8643,8643,8643,8643,8643,8643,8643,8643,86439,04730,84121,23429,39329,26727,86727,85027,8418,3188,2725,7165,7168,2402,5242,5242,5242,5242,5242,5242,52402,609101,52999,44699,44699,44699,44699,44699,16996,95196,93196,86497,29097,23093,48793,32093,32093,31693,30493,25493,18693,19089,40785,50785,44285,43885,40083,60083,00083,00082,80082,70082,70082,70082,70082,70082,70082,60082,70069,10068,60068,70068,70058,40058,30058,20055,50055,30054,70054,70053,00022,9000007,4001,4059,2341,316



6.4. Balance Sheets

Currency in CAD. All numbers in thousands.




6.5. Cash Flows

Currency in CAD. All numbers in thousands.




6.6. Income Statements

Currency in CAD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,286
Cost of Revenue-1,268
Gross Profit1,0181,018
 
Operating Income (+$)
Gross Profit1,018
Operating Expense-13,015
Operating Income-11,997-11,997
 
Operating Expense (+$)
Research Development0
Selling General Administrative11,615
Selling And Marketing Expenses0
Operating Expense13,01511,615
 
Net Interest Income (+$)
Interest Income0
Interest Expense-3,177
Other Finance Cost-0
Net Interest Income-3,177
 
Pretax Income (+$)
Operating Income-11,997
Net Interest Income-3,177
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,395-8,599
EBIT - interestExpense = -15,395
-15,402
-12,225
Interest Expense3,177
Earnings Before Interest and Taxes (EBIT)-12,218-12,218
Earnings Before Interest and Taxes (EBITDA)-11,967
 
After tax Income (+$)
Income Before Tax-15,395
Tax Provision-0
Net Income From Continuing Ops-15,395-15,395
Net Income-15,402
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses14,283
Total Other Income/Expenses Net-3,3983,177
 

Technical Analysis of Spectral Med Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Spectral Med Inc. The general trend of Spectral Med Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Spectral Med Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Spectral Med Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Spectral Med Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.311.

The bearish price targets are: 0.65 > 0.615 > 0.615.

Know someone who trades $EDTXF? Share this with them.πŸ‘‡

Spectral Med Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Spectral Med Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Spectral Med Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Spectral Med Inc. The current macd is 0.12827658.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Spectral Med Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Spectral Med Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Spectral Med Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Spectral Med Inc Daily Moving Average Convergence/Divergence (MACD) ChartSpectral Med Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Spectral Med Inc. The current adx is 71.49.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Spectral Med Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Spectral Med Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Spectral Med Inc. The current sar is 0.84230422.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Spectral Med Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Spectral Med Inc. The current rsi is 67.20. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Spectral Med Inc Daily Relative Strength Index (RSI) ChartSpectral Med Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Spectral Med Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Spectral Med Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Spectral Med Inc Daily Stochastic Oscillator ChartSpectral Med Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Spectral Med Inc. The current cci is 49.82.

Spectral Med Inc Daily Commodity Channel Index (CCI) ChartSpectral Med Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Spectral Med Inc. The current cmo is 16.56.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Spectral Med Inc Daily Chande Momentum Oscillator (CMO) ChartSpectral Med Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Spectral Med Inc. The current willr is -41.93548387.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Spectral Med Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Spectral Med Inc Daily Williams %R ChartSpectral Med Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Spectral Med Inc.

Spectral Med Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Spectral Med Inc. The current atr is 0.05023627.

Spectral Med Inc Daily Average True Range (ATR) ChartSpectral Med Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Spectral Med Inc. The current obv is 1,172,271.

Spectral Med Inc Daily On-Balance Volume (OBV) ChartSpectral Med Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Spectral Med Inc. The current mfi is 67.05.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Spectral Med Inc Daily Money Flow Index (MFI) ChartSpectral Med Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Spectral Med Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Spectral Med Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Spectral Med Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.196
Ma 20Greater thanMa 501.070
Ma 50Greater thanMa 1000.801
Ma 100Greater thanMa 2000.702
OpenGreater thanClose1.210
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Spectral Med Inc with someone you think should read this too:
  • Are you bullish or bearish on Spectral Med Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Spectral Med Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Spectral Med Inc

I send you an email if I find something interesting about Spectral Med Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Spectral Med Inc.

Receive notifications about Spectral Med Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.